Acerta Pharma (A member of the AstraZeneca Group) Email Formats

Pharmaceutical Manufacturing • Oss, North Brabant, Netherlands • 101-200 Employees

Acerta Pharma (A member of the AstraZeneca Group) Email Formats

Acerta Pharma (A member of the AstraZeneca Group) uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@acerta-pharma.com), used 93.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@acerta-pharma.com	95%
{first initial}.{last name}	j.doe@acerta-pharma.com	3.8%
{first initial}.{second initial}{last name}	j.odoe@acerta-pharma.com	1.3%

Key Contacts at Acerta Pharma (A member of the AstraZeneca Group)

Jules Meijerink

Senior Director Bioscience

Eveline Krijger

Director Quality Management

Ellen Klein

Director, Global Study Management

Raj Narlawar

Associate Director

Gerjan De Bruin

Director Medicinal Chemistry

Pearl Lee

Associate Director Bioscience

Gerben Hofman

Global Study Associate Director At Acerta Pharma B.V. A Member Of The Astrazeneca Group

Olaf Kinzel

Senior Director Medicinal Chemistry

Jan Martin Berke

Director Biosciences Haematology Research & Development

Kate Wills

Associate Director, Study Management

Company overview

Headquarters	Kloosterstraat 9, OSS, 5349 AB, NL
Phone number	+31412700574
Website	acerta-pharma.com
NAICS	3254
SIC	283
Keywords	Hematology And Oncology
Founded	2013
Employees	101-200
Socials

About Acerta Pharma (A member of the AstraZeneca Group)

Acerta Pharma is a European R&D centre of the AstraZeneca group dedicated to the discovery and development of novel innovative drugs for the treatment of haematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer. In 2016 AstraZeneca took a majority stake in the company and Acerta Pharma was fully acquired by AstraZeneca in 2021. As part of the significant expansion of our research activities in the Netherlands, we are in the process of building a new research centre in Pivot Park with state-of-the-art research laboratories for more than 140 researchers in Oss, the Netherlands. We are working to develop new treatment options for patients with specific types of blood cancer. Together with our R&D colleagues of AstraZeneca in Gaithersburg, San Francisco, Boston (US), Gothenburg (SE) and Cambridge (UK) we are committed to innovative drug discovery and development, especially in the field of haematological oncology.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Acerta Pharma (A member of the AstraZeneca Group) has 40 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Acerta Pharma (A member of the AstraZeneca Group)'s funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2013-04-14	4	$60,000,000

Funding Insights

$60,000,000

Total funding amount

$60,000,000

Most recent funding amount

Number of funding rounds

Acerta Pharma (A member of the AstraZeneca Group) Tech Stack

Discover the technologies and tools that power Acerta Pharma (A member of the AstraZeneca Group)'s digital infrastructure, from frameworks to analytics platforms.

Adobe Experience Manager

CMS

Kaltura

Livestreaming

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google PageSpeed

Caching

MailChimp

Google Analytics

Analytics

Adobe Analytics

Analytics

Amazon Web Services

PaaS

Google Tag Manager

Tag managers

Java

Programming languages

Adobe Experience Platform Identity Service

Customer data platform

Frequently asked questions

Acerta Pharma (A member of the AstraZeneca Group) is located in Oss, North Brabant, NL.

You can reach Acerta Pharma (A member of the AstraZeneca Group) at +31412700574.

Acerta Pharma (A member of the AstraZeneca Group) was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Acerta Pharma (A member of the AstraZeneca Group) has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Acerta Pharma (A member of the AstraZeneca Group) has raised a total of $60,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.